For far too long, America has been at the mercy of foreign producers that routinely violate FDA safety regulations for life-saving medicines, generic drugs, and essential medical equipment.
It’s the most well-known secret on Capitol Hill: China owns the American generic drug supply chain. Basic thyroid or blood pressure medications might finally be put into pill form in an Indian lab and sold under an Indian brand like Cipla. But the organic compounds, or key starting materials, mostly come from China.
China is forecast to account for 45% of the world’s global industrial production by 2030. That growth comes at the expense of the West, which is projected to drop to 11% of global production in the next five years.
This long-overdue action will protect American manufacturers and workers from the devastating surge of foreign imports that has harmed U.S. industry, particularly from Mexico in blatant violation of the 2019 Joint Steel and Aluminum Agreement.
Jamieson Greer seems certain to be approved as the next United States Trade Representative (USTR), but the Democrats on the Senate Finance Committee proved once again that they are anti-tariff—unless the target is China.
CPA submitted a formal statement of support to the Senate Finance Committee, urging Greer’s confirmation and highlighting his leadership in implementing policies that protected U.S. manufacturers, farmers, and ranchers from being displaced by imports.
As of today, all merchandise originating in China must enter the United States through standard customs procedures, submit full import documentation, and pay applicable duties and taxes—a long-overdue reform to restore order and accountability to America’s trade system.
Valentine will bolster CPA’s advocacy efforts at the federal, state, and local levels, working to advance pro-American trade and economic policies that support domestic manufacturing, strengthen supply chains, and protect American workers.
CPA strongly supports the Trump administration’s expected announcement today imposing 25% universal tariffs on Mexico and Canada and 10% universal tariffs on China—a long-overdue step to rebalance trade, strengthen U.S. manufacturing, and restore American economic independence.
On day one of the new administration, rather than any new tariffs, President Trump issued a Presidential Memorandum titled America First Trade Policy.
Notifications